Comparative <it>in vitro </it>activity of Meropenem, Imipenem and Piperacillin/tazobactam against 1071 clinical isolates using 2 different methods: a French multicentre study
<p>Abstract</p> <p>Background</p> <p>Meropenem is a carbapenem that has an excellent activity against many gram-positive and gram-negative aerobic, facultative, and anaerobic bacteria. The major objective of the present study was to assess the <it>in vitro </it...
Main Authors: | Maugein Jeanne, Dubreuil Luc, Chomarat Monique, Cavallo Jean-Didier, Kempf Marie, Joly-Guillou Marie-Laure, Muller-Serieys Claudette, Roussel-Delvallez Micheline |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2010-03-01
|
Series: | BMC Infectious Diseases |
Online Access: | http://www.biomedcentral.com/1471-2334/10/72 |
Similar Items
-
Retrospective evaluation of piperacillin–tazobactam, imipenem–cilastatin and meropenem used on surgical floors at a tertiary care hospital in Saudi Arabia
by: Eman Youssif, et al.
Published: (2018-07-01) -
The potential of meropenem and piperacillin-tazobactam combination to Acinetobacter spp clinical isolates in vitro
by: Alindya Diani, et al.
Published: (2020-02-01) -
Impact of piperacillin-tazobactam shortage on meropenem use: implications for antimicrobial stewardship programs
by: Katie E. Barber, et al.
Published: (2016-11-01) -
Piperacillin/Tazobactam (ZOSYN)
by: Stephanie M. Culver, et al.
Published: (1996-01-01) -
Randomized Comparison of Piperacillin/Tazobactam Versus Imipenem/Cilastatin in the Treatment of Patients with Intra-abdominal Infection
by: Alex A. Erasmo
Published: (2004-07-01)